Differences between a drug regimen employed in early phase 1 trials and the subsequent use of the agent in routine oncologic practice: a note of caution.
Markman
Maurie
M
Clinical Research, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. mmarkman@mdanderson.org
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D008495:Medical Oncology; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents